ATE403735T1 - Episomaler vektor und dessen verwendung - Google Patents

Episomaler vektor und dessen verwendung

Info

Publication number
ATE403735T1
ATE403735T1 AT96942270T AT96942270T ATE403735T1 AT E403735 T1 ATE403735 T1 AT E403735T1 AT 96942270 T AT96942270 T AT 96942270T AT 96942270 T AT96942270 T AT 96942270T AT E403735 T1 ATE403735 T1 AT E403735T1
Authority
AT
Austria
Prior art keywords
papillomavirus
host cell
episomal vector
recombinant vector
vector
Prior art date
Application number
AT96942270T
Other languages
English (en)
Inventor
Mart Ustav
Original Assignee
Fit Biotech Oyj Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fit Biotech Oyj Plc filed Critical Fit Biotech Oyj Plc
Application granted granted Critical
Publication of ATE403735T1 publication Critical patent/ATE403735T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Inorganic Insulating Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Insulating Materials (AREA)
AT96942270T 1995-12-29 1996-12-27 Episomaler vektor und dessen verwendung ATE403735T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58126995A 1995-12-29 1995-12-29

Publications (1)

Publication Number Publication Date
ATE403735T1 true ATE403735T1 (de) 2008-08-15

Family

ID=24324525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96942270T ATE403735T1 (de) 1995-12-29 1996-12-27 Episomaler vektor und dessen verwendung

Country Status (7)

Country Link
EP (1) EP0870047B1 (de)
AT (1) ATE403735T1 (de)
AU (1) AU1138897A (de)
CA (1) CA2241172C (de)
DE (1) DE69637628D1 (de)
ES (1) ES2312170T3 (de)
WO (1) WO1997024451A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI105105B (fi) * 1998-02-27 2000-06-15 Finnish Immunotechnology Ltd O Itsereplikoiva DNA-vektori immunisoimiseksi HIV:ta vastaan
FI107737B (fi) * 1999-12-23 2001-09-28 Atso Raasmaja Plasmidi tyrosiinihydroksylaasigeenin ilmentämiseksi aivoissa
FI116851B (fi) 2001-05-03 2006-03-15 Fit Biotech Oyj Plc Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita
US7790446B2 (en) * 2005-02-11 2010-09-07 Kosagen Cell Factory Oü Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
EE200700012A (et) * 2007-03-28 2008-12-15 Tartu Ülikool Meetod muudatuste sisseviimiseks eukarootsesse genoomi in vitro ja ex vivo ja komplekt selle jaoks
CN101538581B (zh) * 2009-03-11 2011-10-12 华中农业大学 一种结核分枝杆菌全基因组orf克隆文库的构建方法及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012629A1 (en) * 1992-12-02 1994-06-09 Baylor College Of Medicine Episomal vectors for gene therapy

Also Published As

Publication number Publication date
WO1997024451A2 (en) 1997-07-10
CA2241172C (en) 2008-08-19
WO1997024451A3 (en) 1997-12-18
EP0870047A2 (de) 1998-10-14
EP0870047B1 (de) 2008-08-06
CA2241172A1 (en) 1997-07-10
DE69637628D1 (de) 2008-09-18
ES2312170T3 (es) 2009-02-16
AU1138897A (en) 1997-07-28

Similar Documents

Publication Publication Date Title
HK1030365A1 (en) Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
BR0308919A (pt) Células-tronco programáveis, desdiferenciadas de origem monocìtica, e sua produção e uso
MX9800719A (es) Proteinas de transporte y sus usos.
AU6131086A (en) Epithelial cells expressing foreign genetic material
WO2001023592A3 (en) Methods for making recombinant proteins using apoptosis inhibitors
ATE368118T1 (de) Für enzyme, die die fähigkeit besitzen lineare alpha 1,4-glucane in pflanzen, pilzen und mikroorganismen zu synthesieren, kodierende dna sequenzen
DK0698105T3 (da) Nukleotidsekvenser til styring af ekspressionen af DNAsekvenser i en værtscelle
AU4336499A (en) Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
IL108157A0 (en) An enzyme with endoglucanase activity
HK1023143A1 (en) Intracellular production of hepatitis c e2 truncated polypeptid
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
HUP9901790A2 (hu) Kationos viroszómák mint genetikai anyag bevitelére alkalmas rendszerek
AU1577695A (en) Nucleic acid transfection efficiency increase by use of isopropanol in aqueous solutions
AU6355396A (en) New cationic and polycationic amphiphiles, reactives containing the same and their use
AU8148894A (en) Therapy
CA2097698A1 (en) Human dopamine d4 receptor and its uses
DE69637628D1 (de) Episomaler vektor und dessen verwendung
IL141984A0 (en) Akt nucleic acids, polypeptides, and uses thereof
WO2002062946A3 (en) Identification of novel ms4a gene family members expressed by hematopoietic cells
IL102924A0 (en) Synthetic trnas and their preparation
AU7663296A (en) Use of linalool synthase in genetic engineering of scent production
EP0154566A3 (en) Viral enhancer dna segments
AU4156697A (en) Long-term expression of gene products by transforming muscle cells
MY127675A (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
FI960839A (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties